Pharmaceutical Profiles Limited

In July, 2008; the venture capital group 3i Group was looking to exit their investment in Pharmaceutical Profiles, but was unfamiliar with the sub-sector of unique services that Pharmaceutical Profiles offered. Pharmaceutical Profiles provided early clinical support through reformulation services known as troubled formulation services, and phase 0 study support. 3i Group brought in Crosstree for it's concentration and understanding the the pharmaceutical outsourcing sector.

Within weeks, Crosstree brought in 4 interested parties, all of which were based in Europe. Of the 4 parties, 2 went through the due diligence phase. The process resulted in 3i selling Pharmaceutical Profiles to Quotient Biosciences. Quotient eventually changed Pharmaceutical Profiles to Quotient BioResearch to form Quotient's drug development services group. Crosstree's focus on niche life science sectors helped in understanding Pharmaceutical Profiles' business and the ability to get the right strategic companies involved. This deal also showcases Crosstree's ability to assist with global deals.

Pharmaceutical Profiles Limited provides drug development support to pharmaceutical and biotechnology companies worldwide. It provides clinical support for early drug development programs for oral drugs. The company also offers support in developing inhaled formulations for new and established drugs from the initial formulation concepts through to efficacy testing in patient or healthy volunteers. In addition, it provides first human dose study services using therapeutic doses of intravenous, inhaled, and oral formulations. Pharmaceutical Profiles Limited has a phase I clinical unit, a GMP facility for the manufacture of investigational medicinal products, and formulation R&D facilities in Nottingham, United Kingdom.

Quotient Bioscience Group provides a variety of testing-related products and services through its three divisions: Quotient Bioresearch (offers a variety of clinical drug research services), HFL Sport Science (conducts drug testing of athletes to detect illegal substances), and Alba Bioscience (manufactures products used in blood typing and in other blood testing procedures). The group operates primarily in the UK and North American markets but also serves markets in Europe and Asia.